PATENT CLAIM ANALYSIS

Application Number: 16026886
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-06
Patent Classification: ["514", "023000"]

Abstract:
The present invention features a novel therapy for effecting weight loss which involves treating a subject with a sympathomimetic agent (e.g., phentermine or a phentermine-like drug) in combination with an anticonvulsant sulfamate derivative (e.g., topiramate) such that the subject experiences weight loss. The combination methods of the present invention also are effective against symptoms associated with Syndrome X. The invention also features pharmaceutical compositions and kits for use in the practice of these novel therapies.

Claim (Index 18):
The method of  claim 3 , wherein the composition is administered until the subject has achieved a weight loss of at least 5% compared to the subject's weight prior to administration of the composition.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11385199', '12683353', '11385233', '11385198', '12481548']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7875724247930296
- 35 USC 102 Novelty (BERT): 0.5490479833707335
- Combined Prediction Score: 0.7637199806507999
- Mean Citation Score: 383.953202
- Max Citation Score: 404.74866
- Similarity Product: 251.946633103956

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test